AdvaMed Statement on the PREEMIE Act
WASHINGTON, D.C., – Today, AdvaMed President and CEO Scott Whitaker released the following statement upon House passage of The Prematurity Research Expansion and Education for Mothers who deliver Infants Early (PREEMIE) Reauthorization Act:
“AdvaMed is proud to support the reauthorization of the PREEMIE Act, a bipartisan bill that passed in the House,” said Scott Whitaker, AdvaMed President and CEO. “If we are going to succeed in reducing pre-term births, it is critical that we invest in the research to understand its causes and promote the availability and use of evidence-based standards, especially in minority and underserved communities. The medtech industry is leading the way in improving health outcomes for mothers and babies, and we are committed to working with lawmakers and policymakers in Washington to get these resources, treatments, and tests into the hands of patients who need them most.”
# # #